Mapping Real-world Rebiopsy Events to Treatment Trajectories in EGFR/ALK/ROS1-Driven Non-small-cell Lung Cancer: Insights from the AURORA Cohort
Clinical Lung Cancer · 2026-05 · 27 (4) · 108-116.e2
DOI: 10.1016/j.cllc.2026.03.007 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Lung Cancer, 2026-05. Verfasst von C Williams und 14 weiteren Autor:innen. Beteiligte Einrichtung: Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Vi…. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Proto-Oncogene Proteins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia.
- Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
- School of Pharmacy, Faculty of Health and Biomedical Sciences, RMIT University, Melbourne, Australia.
- Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia. Electronic address: Marliese.Alexander@petermac.org.
Zitieren
APA
Williams, C., Rogers, J., Arasaratnam, D., Pham, T., Nguyen, A., Rashed, L., Tadesse, F., Truong, A., Zhang, H., Selbie, L., Geng, J., Tan, L., Harden, S., Solomon, B. J., & Alexander, M. (2026). Mapping Real-world Rebiopsy Events to Treatment Trajectories in EGFR/ALK/ROS1-Driven Non-small-cell Lung Cancer: Insights from the AURORA Cohort. Clinical Lung Cancer, 27(4), 108-116.e2. https://doi.org/10.1016/j.cllc.2026.03.007
Vancouver
Williams C, Rogers J, Arasaratnam D, Pham T, Nguyen A, Rashed L, et al. Mapping Real-world Rebiopsy Events to Treatment Trajectories in EGFR/ALK/ROS1-Driven Non-small-cell Lung Cancer: Insights from the AURORA Cohort. Clinical Lung Cancer. 2026;27(4):108-116.e2. doi:10.1016/j.cllc.2026.03.007
BibTeX
@article{Williams2026,
author = {Williams, C and Rogers, J and Arasaratnam, D and Pham, T and Nguyen, A and Rashed, L and Tadesse, F and Truong, A and Zhang, H and Selbie, L and Geng, J and Tan, L and Harden, S and Solomon, B J and Alexander, M},
title = {Mapping Real-world Rebiopsy Events to Treatment Trajectories in EGFR/ALK/ROS1-Driven Non-small-cell Lung Cancer: Insights from the AURORA Cohort},
journal = {Clinical Lung Cancer},
year = {2026},
volume = {27},
number = {4},
pages = {108--116.e2},
doi = {10.1016/j.cllc.2026.03.007}
}
EUVIMED